Dr. Brian G.M. Durie discusses key takeaways from the annual conference and explains how this new and important information relates to myeloma patients, caregivers, and other members of the myeloma community.

ASH is the American Society of Hematology. This annual conference welcomed more than 30,000 healthcare professionals from around the world this past December, 2018.

Click here to download slides


Educational grant  provided by:
Celgene, Karyopharm, Sanofi-Genzyme, Takeda Oncology


Previous Post
New Strategies for Multiple Myeloma Care: Next Steps for the Future
Next Post
A Myeloma Warrior Who Inspired Us All

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.